Finshots Daily

Exploring Bihar government's advocacy for a minimum support price for Makhana in the Mithila region, discussing the impact of geographical indication status, profitability for farmers, and challenges like low yield and unorganized markets.

Exploring Karnataka's Draft Gig Workers Bill, the podcast discusses challenges faced by gig workers like losing benefits due to ratings. It questions the effectiveness of proposed solutions such as worker registration and funding. Additionally, it delves into the struggles of gig workers in accessing public facilities and the political dynamics surrounding state bills for worker empowerment.

Exploring China's scrutiny of auditing giants like PwC due to financial irregularities, focusing on the impact on the economy and auditing firms' credibility.

A discussion on SEBI's proposal favoring BSE over NSE in the derivatives market, potential impact on stock brokers, revenue, and profit margins. Analyzing BSE's strategic moves and SEBI's efforts to safeguard investors through regulatory measures like lot size increase and option contract restrictions.

The podcast discusses RBI's worries about microfinance credit growth in Uttar Pradesh and Bihar, highlighting the challenges faced in Andhra Pradesh, regulatory measures by RBI, and the history of microfinance in India.

Delving into why India is a top spot for gold smuggling due to high demand, scarce production, loopholes, corrupt officials, evading duties, illegal transactions, and law enforcement challenges.

Exploring why Kenyans are protesting against the new Finance Bill linked to the IMF's involvement in Kenya's economic difficulties, debt crisis, and the conditions it sets for struggling nations.

Exploring the downfall of the Indian social media app, Koo, compared to Twitter, due to struggles with fundraising, user adoption, and engagement, leading to its shutdown.

Exploring the twist in the Adani vs Hindenburg saga involving Kotak Mahindra Bank's subsidiary short-selling Adani shares, revealing accusations, responses, and the impact on the controversy

Entrepreneur Rishi Shah discusses the billion-dollar pharma advertising scheme, detailing the rise and fall of Outcome Health and the fraudulent tactics used to target patients with chronic diseases.